AccuStem Sciences, Inc. (ACUT)
OTCMKTS
· Delayed Price · Currency is USD
0.280
0.00 (0.00%)
At close: Apr 24, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $4.50 million as of April 29, 2026. Its market cap has increased by 34.45% in one year.
Market Cap
4.50M
Enterprise Value
4.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.28
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 4.50M, a decrease of -77.96%. That is a compound annual growth rate of -30.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 4.50M | -65.58% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 4.22M |
| ZIVO Bioscience | 4.80M |
| GPL Holdings | 4.17M |
| Nymox Pharmaceutical | 4.08M |
| Bioxytran | 3.97M |
| Mosaic ImmunoEngineering | 5.40M |
| Orgenesis | 5.63M |
| Oncology Pharma | 3.48M |